Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice

@inproceedings{Nomura2014XanthineOI,
  title={Xanthine Oxidase Inhibition by Febuxostat Attenuates Experimental Atherosclerosis in Mice},
  author={Johji Nomura and Nathalie Busso and Annette Ives and Chieko Matsui and Syunsuke Tsujimoto and Takashi Shirakura and Mizuho Tamura and Tsunefumi Kobayashi and Alexander Kai-Lik So and Yoshihiro Yamanaka},
  booktitle={Scientific reports},
  year={2014}
}
Atherosclerosis is a chronic inflammatory disease due to lipid deposition in the arterial wall. Multiple mechanisms participate in the inflammatory process, including oxidative stress. Xanthine oxidase (XO) is a major source of reactive oxygen species (ROS) and has been linked to the pathogenesis of atherosclerosis, but the underlying mechanisms remain unclear. Here, we show enhanced XO expression in macrophages in the atherosclerotic plaque and in aortic endothelial cells in ApoE(-/-) mice… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Alcohol abuse is associated with enhanced pulmonary and systemic xanthine oxidoreductase activity.

American journal of physiology. Lung cellular and molecular physiology • 2017
View 4 Excerpts
Highly Influenced

Reaktive Sauerstoffspezies und Gefäßdegeneration

Zeitschrift für Herz-,Thorax- und Gefäßchirurgie • 2018

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients (NU-FLASH Trial).

Circulation journal : official journal of the Japanese Circulation Society • 2013

Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis

P Ye
Clin Ther 35, • 2013

Similar Papers

Loading similar papers…